AlloSource Granted Patent For Innovative Dermal Allograft For Wound Care

News provided by

Dec 22, 2015, 12:38 ET

CENTENNIAL, Colo., Dec. 22, 2015 /PRNewswire/ -- AlloSource®, one of the nation's largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, has been granted a patent for an acellular human dermal matrix processed to be delivered via syringe. U.S. Patent Number 9,162,011, titled Flowable matrix compositions and methods, reinforces the company's commitment to wound care solutions.

The subject of this new patent is an allograft that can be injected or molded by hand for placement in hard-to-reach wounds. Current solutions in AlloSource's wound care portfolio include AlloSkin™ AC Acellular Dermal Matrix (ADM) and AlloSkin™, which is available in both cryopreserved and room temperature storage options.

"A new delivery system is a great example of our ongoing commitment to providing advanced solutions for our healthcare partners," said Thomas Cycyota, AlloSource president and CEO. "We are motivated by the challenge to help heal patients through new uses for donated tissue."

By focusing on quality, safety, service and a commitment to its mission, AlloSource has grown into one of the nations' largest tissue networks in the country. The company's safety and tissue processing standards meet and exceed guidelines set forth by the United States Food and Drug Administration (FDA) and the American Association of Tissue Banks (AATB).

About AlloSource

AlloSource is one of the largest nonprofit cellular and tissue networks in the country, offering more than 200 types of precise cartilage, cellular, bone, skin and soft-tissue allografts to advance patient healing. For more than 20 years, AlloSource's products have bridged the proven science of allografts with the advanced technology of cells, offering life-saving and life-enhancing possibilities in spine, sports medicine, foot and ankle, orthopedic, reconstructive, trauma and wound care procedures. As the world's largest processor of cellular bone allografts, fresh cartilage tissue for joint repair and skin allografts to help heal severe burns, AlloSource delivers unparalleled expertise and service to its growing network of surgeons, partners, and the country's most reputable organ procurement organizations. The company is accredited by the American Association of Tissue Banks and is headquartered in Centennial, CO. For more information, please visit or our educational website, allograftpossibilities.org.

Media Contact
Megan Duggan
AlloSource
720. 382. 2766
[email protected]

SOURCE AlloSource